DeepMed Research

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.eortc.be

Clinical Trials

Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed

Phase 3

Completed

Conditions: Colorectal Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2016-09-02

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 1011

Registration Number: NCT00002523

Locations: 🇧🇪
Hopital Universitaire Erasme, Brussels, Belgium
🇧🇪
Hopital Civil de Charleroi, Charleroi, Belgium
🇧🇪
Clinique Sainte Elisabeth, Namur, Belgium

and more 32 locations

Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma

Phase 3

Conditions: Melanoma (Skin)

Interventions: Biological: pegylated interferon alfa
Procedure: adjuvant therapy

First Posted Date: 2003-01-27

Last Posted Date: 2015-02-10

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 1258

Registration Number: NCT00006249

Locations: 🇳🇱
Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands
🇳🇱
Leiden University Medical Center, Leiden, Netherlands
🇦🇺
David Maddison Clincial Sciences, Newcastle, Australia

and more 100 locations

Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

Phase 2

Completed

Conditions: Endometrial Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Registration Number: NCT00022620

Locations: 🇦🇹
Allgemeines Krankenhaus der Stadt Wien, Vienna, Austria
🇮🇹
Ospedale Mauriziano Umberto I, Torino, Italy
🇬🇧
Queen Elizabeth Hospital, Gateshead, England, United Kingdom

and more 5 locations

Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 51

Registration Number: NCT00006230

Locations: 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇪🇸
Hospital Universitario 12 de Octubre, Madrid, Spain
🇨🇭
Ospedale San Giovanni, Bellinzona, Switzerland

and more 10 locations

Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 40

Registration Number: NCT00027794

Locations: 🇧🇪
Virga Jesse Hospital, Hasselt, Belgium
🇧🇪
U.Z. Gasthuisberg, Leuven, Belgium
🇸🇰
Martin Faculty Hospital, Martin, Slovakia

and more 2 locations

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Phase 3

Terminated

Conditions: Intraocular Melanoma

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 13

Registration Number: NCT00036816

Locations: 🇩🇰
University of Copenhagen, Copenhagen, Denmark
🇧🇪
Cliniques Universitaires Saint-Luc, Brussels, Belgium

Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

Phase 2

Terminated

Conditions: Colorectal Cancer
Metastatic Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 119

Registration Number: NCT00043004

Locations: 🇳🇱
Medisch Spectrum Twente, Enschede, Netherlands
🇭🇺
National Institute of Oncology, Budapest, Hungary
🇬🇧
Churchill Hospital, Oxford, England, United Kingdom

and more 40 locations

Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer

Phase 3

Completed

Conditions: Mediastinal Cancer
Metastatic Cancer
Testicular Germ Cell Tumor

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 222

Registration Number: NCT00003941

Locations: 🇧🇪
Institut Jules Bordet, Brussels (Bruxelles), Belgium
🇩🇪
St. Johannes Hospital - Medical Klinik II, Duisburg, Germany
🇩🇪
Universitaetsklinikum Halle, Halle (Saale), Germany

and more 34 locations

Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Phase 3

Terminated

Conditions: Gastric Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 144

Registration Number: NCT00004099

Locations: 🇧🇪
Institut Jules Bordet, Brussels, Belgium
🇩🇪
Universitaetsklinik Duesseldorf, Duesseldorf, Germany
🇩🇪
Klinik & Poliklinik fur Strahlentherapie der Universitat zu Koln, Koln, Germany

and more 15 locations

Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer

Phase 2

Completed

Conditions: Endometrial Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2012-09-24

Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Target Recruit Count: 141

Registration Number: NCT00052312

Locations: 🇧🇪
Universitair Ziekenhuis Antwerpen, Edegem, Belgium
🇪🇸
Hospital Universitario 12 de Octubre, Madrid, Spain
🇪🇸
Instituto Valenciano De Oncologia, Valencia, Spain

and more 32 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy